Search Results

Keywords: "United Kingdom"

England’s health insurance has covered only 18 ‘unlicensed’ cannabis prescriptions

November 19, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. In the case of private prescriptions – which are paid out of pocket by patients – the number of prescriptions reached 104. The data […]

Read More

Week in Review: Cannabis layoffs, regulators scrutinizing vitamin E acetate as vape villain, MI adult-use launch looms & more

November 15, 2019 · Updated November 18, 2019

Layoff announcements continue to weigh on the marijuana industry, state regulators focus on vitamin E acetate additive in vaporizer products as the vape crisis continues, Michigan businesses set their game plans for a December adult-use MJ launch, and more of the week’s top cannabis news. Pink slips pile up  Three well-known California cannabis companies this […]

Read More

New UK guidelines recommend public insurance coverage for two GW Pharma cannabis medicines, plus a synthetic cannabinoid

November 12, 2019 · Updated October 13, 2021

New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex – be covered through the United Kingdom’s National Health Service (NHS), a significant step that is likely to boost sales of both products. Health regulators also are recommending the NHS make available a synthetic cannabinoid known as nabilone. […]

Read More

France appears ready to OK funding for a medical cannabis experiment with 3,000 patients

October 14, 2019 · Updated October 15, 2019

French lawmakers appear ready to approve legislation to bankroll a two-year medical cannabis trial program for 3,000 patients, a move that would give overseas companies the opportunity to export product to what could become one of Europe’s largest markets. Olivier Véran, deputy of the French National Assembly, submitted an amendment to the Social Security Financing Bill (Projet de […]

Read More

Wellness products take off in the growing recreational cannabis market

October 1, 2019 · Updated June 6, 2021

Is the U.S. medical marijuana industry doomed? Amid news reports suggesting that MMJ markets are plateauing or shrinking in some states—particularly those that have approved the recreational use of marijuana, it’s reasonable to believe cannabis executives are bailing out of medical and plowing resources into adult-use products. Not so. Many cannabis companies are doubling down […]

Read More

European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says

September 23, 2019

The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age and older. The CBD-based medicine was greenlighted in Europe […]

Read More

Global Cannabis: Seven Global Players Worth Watching

September 6, 2019 · Updated February 19, 2021

There are seven businesses worth watching as they attempt to capitalize on the numerous business opportunities in the global marijuana market for entrepreneurs and companies with ambition. And check often for new updates. Looking for where else the action is taking place in the global cannabis market? Here is our list of seven countries to keep […]

Read More

New Zealand’s marijuana legalization referendum picks up major backer

September 4, 2019

Former New Zealand Prime Minister Helen Clark is supporting the nation’s binding 2020 referendum on ending cannabis prohibition. In an opinion piece published in the United Kingdom’s Guardian newspaper titled “Cannabis prohibition doesn’t work anywhere; It’s New Zealand’s turn to legalize it,” Clark urged voters to make New Zealand the first Group of 20 nation […]

Read More

Cannabis firm Atlas expands to Denmark, plans large indoor production

September 3, 2019

Edmonton, Alberta-based Atlas Biotechnologies is expanding to Denmark, where the Canadian producer plans to repurpose a sprawling indoor mushroom farm for medical cannabis cultivation. The initiative, expected to cost 40 million-50 million Canadian dollars ($27 million-$37 million), aims to be fully operational by the end of 2020. Atlas follows in the footsteps of Canada-based international […]

Read More